Westchester Capital Management (New York)’s Molecular Partners MOLN Stock Holding History
Bought
Maintained
Sold
Other funds holding MOLN
BI
SCM
Westchester Capital Management (New York)'s MOLN Position: Q1 2022 in Review
Westchester Capital Management (New York) sold out of Molecular Partners (MOLN) in Q1 2022, closing a stake of 1,000 shares — an estimated $20K sold.
Westchester Capital Management (New York) first reported a position in MOLN in Q2 2021 and held it in 3 quarters. The position peaked at $20K in Q4 2021. 8 funds tracked by Wall St. Rank hold MOLN as of Q1 2022.
- Westchester Capital Management (New York) reported no remaining Molecular Partners position as of Q1 2022 after selling out during the quarter.
- Westchester Capital Management (New York) sold 1,000 Molecular Partners shares in Q1 2022, an estimated $20K.
- Westchester Capital Management (New York) first reported a position in Molecular Partners in Q2 2021 and held it in 3 quarters.
- Westchester Capital Management (New York)'s Molecular Partners position peaked at $20K in Q4 2021.
- 8 funds tracked by Wall St. Rank held Molecular Partners as of Q1 2022.
Based on Westchester Capital Management (New York)'s 13F filing for Q1 2022, filed 16 May 2022.